author_facet Yang, Vicky K.
Loughran, Kerry A.
Meola, Dawn M.
Juhr, Christine M.
Thane, Kristen E.
Davis, Airiel M.
Hoffman, Andrew M.
Yang, Vicky K.
Loughran, Kerry A.
Meola, Dawn M.
Juhr, Christine M.
Thane, Kristen E.
Davis, Airiel M.
Hoffman, Andrew M.
author Yang, Vicky K.
Loughran, Kerry A.
Meola, Dawn M.
Juhr, Christine M.
Thane, Kristen E.
Davis, Airiel M.
Hoffman, Andrew M.
spellingShingle Yang, Vicky K.
Loughran, Kerry A.
Meola, Dawn M.
Juhr, Christine M.
Thane, Kristen E.
Davis, Airiel M.
Hoffman, Andrew M.
Journal of Extracellular Vesicles
Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
Cell Biology
Histology
author_sort yang, vicky k.
spelling Yang, Vicky K. Loughran, Kerry A. Meola, Dawn M. Juhr, Christine M. Thane, Kristen E. Davis, Airiel M. Hoffman, Andrew M. 2001-3078 2001-3078 Wiley Cell Biology Histology http://dx.doi.org/10.1080/20013078.2017.1350088 <jats:title>ABSTRACT</jats:title><jats:p>Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical treatments that can delay the progression of this valvular disease or associated cardiac remodelling. Therefore, there is a need to understand the molecular pathology associated with MMVD and MVP better, and thus identify potential therapeutic targets. Circulating exosomes contain small RNA, including miRNA, which reflect cell physiology and pathology. This study explored the association between circulating exosomal miRNA (ex‐miRNA) content and MMVD, heart failure due to MMVD (MMVD‐CHF) and ageing, which is strongly associated with MMVD. Ex‐miRNA was isolated from old normal/healthy dogs (<jats:italic>n</jats:italic> = 6), young normal dogs (<jats:italic>n</jats:italic> = 7), dogs with MMVD (<jats:italic>n</jats:italic> = 7) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 7). Separately, total plasma miRNA was isolated from normal dogs (<jats:italic>n</jats:italic> = 8), dogs with MMVD (<jats:italic>n</jats:italic> = 8) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 11). Using reverse transcription quantitative polymerase chain reaction, exosomal miR‐181c (<jats:italic>p</jats:italic> = 0.003) and miR‐495 (<jats:italic>p</jats:italic> = 0.0001) significantly increased in dogs with MMVD‐CHF compared to the other three groups. Exosomal miR‐9 (<jats:italic>p</jats:italic> = 0.002) increased in dogs with MMVD and MMVD‐CHF compared to age‐matched (old) normal dogs. Exosomal miR‐599 (<jats:italic>p</jats:italic> = 0.002) decreased in dogs with MMVD compared to old normal dogs. In total plasma, 58 miRNA were deemed significantly different (<jats:italic>p</jats:italic> &lt; 0.04) between normal dogs, dogs with MMVD and dogs with MMVD‐CHF. However, in contrast to ex‐miRNA, none of the miRNA in total plasma remained statistically significant if the false discovery rate was &lt;15%. Changes in ex‐miRNA are observed in dogs as they age (miR‐9, miR‐495 and miR‐599), develop MMVD (miR‐9 and miR‐599) and progress from MMVD to CHF (miR‐181c and miR‐495). Ex‐miRNA expression‐level changes appear to be more specific to disease states than total plasma miRNA.</jats:p><jats:p><jats:disp-quote content-type="quotation"><jats:p><jats:bold>RESPONSIBLE EDITOR</jats:bold> Elena Aikawa, Harvard Medical School, USA</jats:p></jats:disp-quote></jats:p> Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model Journal of Extracellular Vesicles
doi_str_mv 10.1080/20013078.2017.1350088
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8yMDAxMzA3OC4yMDE3LjEzNTAwODg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8yMDAxMzA3OC4yMDE3LjEzNTAwODg
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Wiley, 2017
imprint_str_mv Wiley, 2017
issn 2001-3078
issn_str_mv 2001-3078
language English
mega_collection Wiley (CrossRef)
match_str yang2017circulatingexosomemicrornaassociatedwithheartfailuresecondarytomyxomatousmitralvalvediseaseinanaturallyoccurringcaninemodel
publishDateSort 2017
publisher Wiley
recordtype ai
record_format ai
series Journal of Extracellular Vesicles
source_id 49
title Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_unstemmed Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_full Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_fullStr Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_full_unstemmed Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_short Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_sort circulating exosome microrna associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
topic Cell Biology
Histology
url http://dx.doi.org/10.1080/20013078.2017.1350088
publishDate 2017
physical
description <jats:title>ABSTRACT</jats:title><jats:p>Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical treatments that can delay the progression of this valvular disease or associated cardiac remodelling. Therefore, there is a need to understand the molecular pathology associated with MMVD and MVP better, and thus identify potential therapeutic targets. Circulating exosomes contain small RNA, including miRNA, which reflect cell physiology and pathology. This study explored the association between circulating exosomal miRNA (ex‐miRNA) content and MMVD, heart failure due to MMVD (MMVD‐CHF) and ageing, which is strongly associated with MMVD. Ex‐miRNA was isolated from old normal/healthy dogs (<jats:italic>n</jats:italic> = 6), young normal dogs (<jats:italic>n</jats:italic> = 7), dogs with MMVD (<jats:italic>n</jats:italic> = 7) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 7). Separately, total plasma miRNA was isolated from normal dogs (<jats:italic>n</jats:italic> = 8), dogs with MMVD (<jats:italic>n</jats:italic> = 8) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 11). Using reverse transcription quantitative polymerase chain reaction, exosomal miR‐181c (<jats:italic>p</jats:italic> = 0.003) and miR‐495 (<jats:italic>p</jats:italic> = 0.0001) significantly increased in dogs with MMVD‐CHF compared to the other three groups. Exosomal miR‐9 (<jats:italic>p</jats:italic> = 0.002) increased in dogs with MMVD and MMVD‐CHF compared to age‐matched (old) normal dogs. Exosomal miR‐599 (<jats:italic>p</jats:italic> = 0.002) decreased in dogs with MMVD compared to old normal dogs. In total plasma, 58 miRNA were deemed significantly different (<jats:italic>p</jats:italic> &lt; 0.04) between normal dogs, dogs with MMVD and dogs with MMVD‐CHF. However, in contrast to ex‐miRNA, none of the miRNA in total plasma remained statistically significant if the false discovery rate was &lt;15%. Changes in ex‐miRNA are observed in dogs as they age (miR‐9, miR‐495 and miR‐599), develop MMVD (miR‐9 and miR‐599) and progress from MMVD to CHF (miR‐181c and miR‐495). Ex‐miRNA expression‐level changes appear to be more specific to disease states than total plasma miRNA.</jats:p><jats:p><jats:disp-quote content-type="quotation"><jats:p><jats:bold>RESPONSIBLE EDITOR</jats:bold> Elena Aikawa, Harvard Medical School, USA</jats:p></jats:disp-quote></jats:p>
container_issue 1
container_start_page 0
container_title Journal of Extracellular Vesicles
container_volume 6
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347757832306688
geogr_code not assigned
last_indexed 2024-03-01T18:00:22.002Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Circulating+exosome+microRNA+associated+with+heart+failure+secondary+to+myxomatous+mitral+valve+disease+in+a+naturally+occurring+canine+model&rft.date=2017-12-01&genre=article&issn=2001-3078&volume=6&issue=1&jtitle=Journal+of+Extracellular+Vesicles&atitle=Circulating+exosome+microRNA+associated+with+heart+failure+secondary+to+myxomatous+mitral+valve+disease+in+a+naturally+occurring+canine+model&aulast=Hoffman&aufirst=Andrew+M.&rft_id=info%3Adoi%2F10.1080%2F20013078.2017.1350088&rft.language%5B0%5D=eng
SOLR
_version_ 1792347757832306688
author Yang, Vicky K., Loughran, Kerry A., Meola, Dawn M., Juhr, Christine M., Thane, Kristen E., Davis, Airiel M., Hoffman, Andrew M.
author_facet Yang, Vicky K., Loughran, Kerry A., Meola, Dawn M., Juhr, Christine M., Thane, Kristen E., Davis, Airiel M., Hoffman, Andrew M., Yang, Vicky K., Loughran, Kerry A., Meola, Dawn M., Juhr, Christine M., Thane, Kristen E., Davis, Airiel M., Hoffman, Andrew M.
author_sort yang, vicky k.
container_issue 1
container_start_page 0
container_title Journal of Extracellular Vesicles
container_volume 6
description <jats:title>ABSTRACT</jats:title><jats:p>Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical treatments that can delay the progression of this valvular disease or associated cardiac remodelling. Therefore, there is a need to understand the molecular pathology associated with MMVD and MVP better, and thus identify potential therapeutic targets. Circulating exosomes contain small RNA, including miRNA, which reflect cell physiology and pathology. This study explored the association between circulating exosomal miRNA (ex‐miRNA) content and MMVD, heart failure due to MMVD (MMVD‐CHF) and ageing, which is strongly associated with MMVD. Ex‐miRNA was isolated from old normal/healthy dogs (<jats:italic>n</jats:italic> = 6), young normal dogs (<jats:italic>n</jats:italic> = 7), dogs with MMVD (<jats:italic>n</jats:italic> = 7) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 7). Separately, total plasma miRNA was isolated from normal dogs (<jats:italic>n</jats:italic> = 8), dogs with MMVD (<jats:italic>n</jats:italic> = 8) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 11). Using reverse transcription quantitative polymerase chain reaction, exosomal miR‐181c (<jats:italic>p</jats:italic> = 0.003) and miR‐495 (<jats:italic>p</jats:italic> = 0.0001) significantly increased in dogs with MMVD‐CHF compared to the other three groups. Exosomal miR‐9 (<jats:italic>p</jats:italic> = 0.002) increased in dogs with MMVD and MMVD‐CHF compared to age‐matched (old) normal dogs. Exosomal miR‐599 (<jats:italic>p</jats:italic> = 0.002) decreased in dogs with MMVD compared to old normal dogs. In total plasma, 58 miRNA were deemed significantly different (<jats:italic>p</jats:italic> &lt; 0.04) between normal dogs, dogs with MMVD and dogs with MMVD‐CHF. However, in contrast to ex‐miRNA, none of the miRNA in total plasma remained statistically significant if the false discovery rate was &lt;15%. Changes in ex‐miRNA are observed in dogs as they age (miR‐9, miR‐495 and miR‐599), develop MMVD (miR‐9 and miR‐599) and progress from MMVD to CHF (miR‐181c and miR‐495). Ex‐miRNA expression‐level changes appear to be more specific to disease states than total plasma miRNA.</jats:p><jats:p><jats:disp-quote content-type="quotation"><jats:p><jats:bold>RESPONSIBLE EDITOR</jats:bold> Elena Aikawa, Harvard Medical School, USA</jats:p></jats:disp-quote></jats:p>
doi_str_mv 10.1080/20013078.2017.1350088
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8yMDAxMzA3OC4yMDE3LjEzNTAwODg
imprint Wiley, 2017
imprint_str_mv Wiley, 2017
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 2001-3078
issn_str_mv 2001-3078
language English
last_indexed 2024-03-01T18:00:22.002Z
match_str yang2017circulatingexosomemicrornaassociatedwithheartfailuresecondarytomyxomatousmitralvalvediseaseinanaturallyoccurringcaninemodel
mega_collection Wiley (CrossRef)
physical
publishDate 2017
publishDateSort 2017
publisher Wiley
record_format ai
recordtype ai
series Journal of Extracellular Vesicles
source_id 49
spelling Yang, Vicky K. Loughran, Kerry A. Meola, Dawn M. Juhr, Christine M. Thane, Kristen E. Davis, Airiel M. Hoffman, Andrew M. 2001-3078 2001-3078 Wiley Cell Biology Histology http://dx.doi.org/10.1080/20013078.2017.1350088 <jats:title>ABSTRACT</jats:title><jats:p>Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical treatments that can delay the progression of this valvular disease or associated cardiac remodelling. Therefore, there is a need to understand the molecular pathology associated with MMVD and MVP better, and thus identify potential therapeutic targets. Circulating exosomes contain small RNA, including miRNA, which reflect cell physiology and pathology. This study explored the association between circulating exosomal miRNA (ex‐miRNA) content and MMVD, heart failure due to MMVD (MMVD‐CHF) and ageing, which is strongly associated with MMVD. Ex‐miRNA was isolated from old normal/healthy dogs (<jats:italic>n</jats:italic> = 6), young normal dogs (<jats:italic>n</jats:italic> = 7), dogs with MMVD (<jats:italic>n</jats:italic> = 7) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 7). Separately, total plasma miRNA was isolated from normal dogs (<jats:italic>n</jats:italic> = 8), dogs with MMVD (<jats:italic>n</jats:italic> = 8) and dogs with MMVD‐CHF (<jats:italic>n</jats:italic> = 11). Using reverse transcription quantitative polymerase chain reaction, exosomal miR‐181c (<jats:italic>p</jats:italic> = 0.003) and miR‐495 (<jats:italic>p</jats:italic> = 0.0001) significantly increased in dogs with MMVD‐CHF compared to the other three groups. Exosomal miR‐9 (<jats:italic>p</jats:italic> = 0.002) increased in dogs with MMVD and MMVD‐CHF compared to age‐matched (old) normal dogs. Exosomal miR‐599 (<jats:italic>p</jats:italic> = 0.002) decreased in dogs with MMVD compared to old normal dogs. In total plasma, 58 miRNA were deemed significantly different (<jats:italic>p</jats:italic> &lt; 0.04) between normal dogs, dogs with MMVD and dogs with MMVD‐CHF. However, in contrast to ex‐miRNA, none of the miRNA in total plasma remained statistically significant if the false discovery rate was &lt;15%. Changes in ex‐miRNA are observed in dogs as they age (miR‐9, miR‐495 and miR‐599), develop MMVD (miR‐9 and miR‐599) and progress from MMVD to CHF (miR‐181c and miR‐495). Ex‐miRNA expression‐level changes appear to be more specific to disease states than total plasma miRNA.</jats:p><jats:p><jats:disp-quote content-type="quotation"><jats:p><jats:bold>RESPONSIBLE EDITOR</jats:bold> Elena Aikawa, Harvard Medical School, USA</jats:p></jats:disp-quote></jats:p> Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model Journal of Extracellular Vesicles
spellingShingle Yang, Vicky K., Loughran, Kerry A., Meola, Dawn M., Juhr, Christine M., Thane, Kristen E., Davis, Airiel M., Hoffman, Andrew M., Journal of Extracellular Vesicles, Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model, Cell Biology, Histology
title Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_full Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_fullStr Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_full_unstemmed Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_short Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_sort circulating exosome microrna associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
title_unstemmed Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model
topic Cell Biology, Histology
url http://dx.doi.org/10.1080/20013078.2017.1350088